LeonaBio (LONA) Other Working Capital Changes (2019 - 2026)
LeonaBio (LONA) reported Other Working Capital Changes of -$112000.0 for Q1 2026, down 12.0% year-over-year from -$127272.7 in Q1 2025, and down 106.56% quarter-over-quarter from $1.7 million in Q4 2025.
LeonaBio (LONA) Other Working Capital Changes (2019 - 2026) Analysis & Trends
LeonaBio (LONA) has 8 years of Other Working Capital Changes data on file, last reported at -$112000.0 in Q1 2026.
- Other Working Capital Changes for Q1 2026 came in at -$112000.0, down 12.0% year-over-year; the trailing twelve-month figure through Mar 2026 was -$71000.0 (up 81.36% YoY), and the FY2025 annual result was -$59000.0, up 83.97% from the prior year.
- Other Working Capital Changes fell to -$112000.0 in Q1 2026 per LONA's latest filing, from $1.7 million in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $1.7 million in Q4 2025 and troughed at -$1.1 million in Q2 2023.
- A 5-year average of -$25941.2 and a median of -$97000.0 in 2024 frame the typical range for Other Working Capital Changes.
- The sharpest annual moves came in 2022 and 2025: Other Working Capital Changes sank 6252.94% in 2022, then soared 1860.82% in 2025.
- A 5-year view of Other Working Capital Changes shows it stood at $197000.0 in 2022, then tumbled by 228.43% to -$253000.0 in 2023, then soared by 61.66% to -$97000.0 in 2024, then soared by 1860.82% to $1.7 million in 2025, then plunged by 106.56% to -$112000.0 in 2026.
- Business Quant data shows LONA's Other Working Capital Changes at -$112000.0 in Q1 2026, $1.7 million in Q4 2025, and -$603000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | LeonaBio | 154.12 Mn | 86.44 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -112,000.00 |
| Mar 31, 2026 | -112,000.00 |
| Dec 31, 2025 | 1.71 Mn |
| Dec 31, 2025 | 1.71 Mn |
| Sep 30, 2025 | -603,000.00 |
| Sep 30, 2025 | -603,000.00 |
| Jun 30, 2025 | -1.06 Mn |
| Jun 30, 2025 | -1.06 Mn |
| Mar 31, 2025 | -100,000.00 |
| Mar 31, 2025 | -100,000.00 |
| Dec 31, 2024 | -97,000.00 |
| Dec 31, 2024 | -97,000.00 |
| Sep 30, 2024 | 870,000.00 |
| Sep 30, 2024 | 870,000.00 |
| Jun 30, 2024 | -1.05 Mn |
| Jun 30, 2024 | -1.05 Mn |
| Mar 31, 2024 | -87,000.00 |
| Mar 31, 2024 | -87,000.00 |
| Dec 31, 2023 | -253,000.00 |
| Dec 31, 2023 | -253,000.00 |